Bifogade filer
25012022 allocation of share options
Kurs
+0,81%
Kurs
+0,81%
Open
943,00
High
977,40
Low
937,00
Close
947,00
Kursutveckling under dagen för detta pressmeddelande
(DKK).
Likviditet
341 MDKK
Likviditet
341 MDKK
Rel. mcap
0,26%
Antal aktier
356 421
Likviditet under dagen för detta pressmeddelande
Kalender
| Est. tid* | ||
| 2026-12-03 | N/A | Årsstämma |
| 2026-11-05 | 12:10 | Bokslutskommuniké 2026 |
| 2026-08-18 | 07:30 | Kvartalsrapport 2026-Q3 |
| 2026-05-12 | 07:30 | Kvartalsrapport 2026-Q2 |
| 2026-02-06 | 07:30 | Kvartalsrapport 2026-Q1 |
| 2025-12-04 | N/A | Årsstämma |
| 2025-11-04 | 12:10 | Bokslutskommuniké 2025 |
| 2025-08-19 | - | Kvartalsrapport 2025-Q3 |
| 2025-05-08 | - | X-dag halvårsutdelning COLO B 5 |
| 2025-05-06 | - | Kvartalsrapport 2025-Q2 |
| 2025-02-04 | - | Kvartalsrapport 2025-Q1 |
| 2024-12-06 | - | X-dag halvårsutdelning COLO B 17 |
| 2024-12-05 | - | Årsstämma |
| 2024-11-05 | - | Bokslutskommuniké 2024 |
| 2024-08-20 | - | Kvartalsrapport 2024-Q3 |
| 2024-05-13 | - | X-dag halvårsutdelning COLO B 5 |
| 2024-05-07 | - | Kvartalsrapport 2024-Q2 |
| 2024-02-09 | - | Kvartalsrapport 2024-Q1 |
| 2023-12-08 | - | X-dag halvårsutdelning COLO B 16 |
| 2023-12-07 | - | Årsstämma |
| 2023-11-09 | - | Bokslutskommuniké 2023 |
| 2023-08-17 | - | Kvartalsrapport 2023-Q3 |
| 2023-05-15 | - | X-dag halvårsutdelning COLO B 5 |
| 2023-05-11 | - | Kvartalsrapport 2023-Q2 |
| 2023-02-03 | - | Kvartalsrapport 2023-Q1 |
| 2022-12-02 | - | X-dag halvårsutdelning COLO B 15 |
| 2022-12-01 | - | Årsstämma |
| 2022-11-07 | - | Bokslutskommuniké 2022 |
| 2022-08-17 | - | Kvartalsrapport 2022-Q3 |
| 2022-05-09 | - | X-dag halvårsutdelning COLO B 5 |
| 2022-05-05 | - | Kvartalsrapport 2022-Q2 |
| 2022-01-25 | - | Kvartalsrapport 2022-Q1 |
| 2021-12-03 | - | X-dag halvårsutdelning COLO B 14 |
| 2021-12-02 | - | Årsstämma |
| 2021-11-01 | - | Bokslutskommuniké 2021 |
| 2021-08-18 | - | Kvartalsrapport 2021-Q3 |
| 2021-05-10 | - | X-dag halvårsutdelning COLO B 5 |
| 2021-05-06 | - | Kvartalsrapport 2021-Q2 |
| 2021-02-06 | - | Kvartalsrapport 2021-Q1 |
| 2020-12-04 | - | X-dag halvårsutdelning COLO B 13 |
| 2020-12-03 | - | Årsstämma |
| 2020-11-03 | - | Bokslutskommuniké 2020 |
| 2020-08-18 | - | Kvartalsrapport 2020-Q3 |
| 2020-05-11 | - | X-dag halvårsutdelning COLO B 5 |
| 2020-05-06 | - | Kvartalsrapport 2020-Q2 |
| 2020-02-06 | - | Kvartalsrapport 2020-Q1 |
| 2019-12-06 | - | X-dag halvårsutdelning COLO B 12 |
| 2019-12-05 | - | Årsstämma |
| 2019-11-05 | - | Bokslutskommuniké 2019 |
| 2019-08-14 | - | Kvartalsrapport 2019-Q3 |
| 2019-05-06 | - | X-dag halvårsutdelning COLO B 5 |
| 2019-05-02 | - | Kvartalsrapport 2019-Q2 |
| 2019-02-05 | - | Kvartalsrapport 2019-Q1 |
| 2018-12-06 | - | X-dag halvårsutdelning COLO B 11 |
| 2018-12-05 | - | Årsstämma |
| 2018-11-01 | - | Bokslutskommuniké 2018 |
| 2018-08-08 | - | Kvartalsrapport 2018-Q3 |
| 2018-05-07 | - | X-dag halvårsutdelning COLO B 5 |
| 2018-05-03 | - | Kvartalsrapport 2018-Q2 |
| 2018-02-01 | - | Kvartalsrapport 2018-Q1 |
| 2017-12-08 | - | X-dag halvårsutdelning COLO B 10.5 |
| 2017-12-07 | - | Årsstämma |
| 2017-11-02 | - | Bokslutskommuniké 2017 |
| 2017-08-16 | - | Kvartalsrapport 2017-Q3 |
| 2017-05-08 | - | X-dag halvårsutdelning COLO B 4.5 |
| 2017-05-03 | - | Kvartalsrapport 2017-Q2 |
| 2017-02-01 | - | Kvartalsrapport 2017-Q1 |
| 2016-12-06 | - | X-dag halvårsutdelning COLO B 9 |
| 2016-12-05 | - | Årsstämma |
| 2016-11-02 | - | Bokslutskommuniké 2016 |
| 2016-08-16 | - | Kvartalsrapport 2016-Q3 |
| 2016-05-09 | - | X-dag halvårsutdelning COLO B 4.5 |
| 2016-05-03 | - | Kvartalsrapport 2016-Q2 |
| 2016-02-02 | - | Kvartalsrapport 2016-Q1 |
| 2015-12-10 | - | X-dag halvårsutdelning COLO B 8 |
| 2015-12-09 | - | Årsstämma |
| 2015-11-03 | - | Bokslutskommuniké 2015 |
| 2015-08-11 | - | Kvartalsrapport 2015-Q3 |
| 2015-05-07 | - | X-dag halvårsutdelning COLO B 4.5 |
| 2015-05-05 | - | Kvartalsrapport 2015-Q2 |
| 2015-01-29 | - | Kvartalsrapport 2015-Q1 |
| 2014-12-05 | - | X-dag halvårsutdelning COLO B 7.5 |
| 2014-12-04 | - | Årsstämma |
| 2014-10-30 | - | Bokslutskommuniké 2014 |
| 2014-05-08 | - | X-dag halvårsutdelning COLO B 4 |
| 2013-12-06 | - | X-dag halvårsutdelning COLO B 7 |
| 2013-12-05 | - | Årsstämma |
| 2013-10-31 | - | Bokslutskommuniké 2013 |
| 2013-08-13 | - | Kvartalsrapport 2013-Q3 |
| 2013-05-06 | - | X-dag halvårsutdelning COLO B 3 |
| 2013-04-30 | - | Kvartalsrapport 2013-Q2 |
| 2013-01-30 | - | Kvartalsrapport 2013-Q1 |
| 2012-12-19 | - | Split COLO B 1:5 |
| 2012-12-11 | - | Årsstämma |
| 2012-11-06 | - | Bokslutskommuniké 2012 |
| 2012-08-15 | - | Kvartalsrapport 2012-Q3 |
| 2012-04-26 | - | Kvartalsrapport 2012-Q2 |
| 2012-01-25 | - | Kvartalsrapport 2012-Q1 |
| 2011-12-08 | - | X-dag ordinarie utdelning COLO B 14.00 DKK |
| 2011-12-07 | - | Årsstämma |
| 2011-11-01 | - | Bokslutskommuniké 2011 |
| 2011-08-17 | - | Kvartalsrapport 2011-Q3 |
| 2011-06-21 | - | Kapitalmarknadsdag 2011 |
| 2011-05-04 | - | Kvartalsrapport 2011-Q2 |
| 2011-01-26 | - | Kvartalsrapport 2011-Q1 |
| 2010-12-02 | - | X-dag ordinarie utdelning COLO B 10.00 DKK |
| 2009-12-02 | - | X-dag ordinarie utdelning COLO B 7.00 DKK |
| 2004-12-16 | - | Split COLO B 1:2 |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2022-01-25 13:08:38
Report on transactions of executives and related parties in Coloplast shares and related securities
According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.
The below transactions concern allocation of share options.
For further details, reference is made to Coloplast’s Remuneration Policy which was adopted in 2021. The policy is available on the group website at this address:
https://investor.coloplast.com/investor-relations/governance/policies_and_positions/
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Kristian Villumsen | |
| 2 | Reason for the notification | ||
| a) | Position/status | President & CEO | |
| b) | Initial notification/Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor | ||
| a) | Name | Coloplast A/S (CVR-no.: 69749917) | |
| b) | LEI | 529900NN7SOJ5QG82X67 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Share options relating to B shares | |
| Identification code | ISIN: DK0060448595 (B shares) | ||
| b) | Nature of the transaction | Share option allocation | |
| c) | Price and volume | Price | Volume |
| 0.00 | 47,454 | ||
| d) | Aggregated information | ||
| - Aggregated volume | 47,454 share options | ||
| - Price | DKK 0.00 | ||
| e) | Date of the transaction | 2022-01-25, 12:00 UTC | |
| f) | Place of the transaction | Outside a trading venue | |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Anders Lonning-Skovgaard | |
| 2 | Reason for the notification | ||
| a) | Position/status | Executive Vice President & CFO | |
| b) | Initial notification/Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor | ||
| a) | Name | Coloplast A/S (CVR-no.: 69749917) | |
| b) | LEI | 529900NN7SOJ5QG82X67 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Share options relating to B shares | |
| Identification code | ISIN: DK0060448595 (B shares) | ||
| b) | Nature of the transaction | Share option allocation | |
| c) | Price and volume | Price | Volume |
| 0.00 | 23,465 | ||
| d) | Aggregated information | ||
| - Aggregated volume | 23,465 share options | ||
| - Price | DKK 0.00 | ||
| e) | Date of the transaction | 2022-01-25, 12:00 UTC | |
| f) | Place of the transaction | Outside a trading venue | |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Paul Marcun | |
| 2 | Reason for the notification | ||
| a) | Position/status | Executive Vice President, Growth | |
| b) | Initial notification/Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor | ||
| a) | Name | Coloplast A/S (CVR-no.: 69749917) | |
| b) | LEI | 529900NN7SOJ5QG82X67 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Share options relating to B shares | |
| Identification code | ISIN: DK0060448595 (B shares) | ||
| b) | Nature of the transaction | Share option allocation | |
| c) | Price and volume | Price | Volume |
| 0.00 | 24,048 | ||
| d) | Aggregated information | ||
| - Aggregated volume | 24,048 share options | ||
| - Price | DKK 0.00 | ||
| e) | Date of the transaction | 2022-01-25, 12:00 UTC | |
| f) | Place of the transaction | Outside a trading venue | |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Allan Rasmussen | |
| 2 | Reason for the notification | ||
| a) | Position/status | Executive Vice President, Global Operations | |
| b) | Initial notification/Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor | ||
| a) | Name | Coloplast A/S (CVR-no.: 69749917) | |
| b) | LEI | 529900NN7SOJ5QG82X67 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Share options relating to B shares | |
| Identification code | ISIN: DK0060448595 (B shares) | ||
| b) | Nature of the transaction | Share option allocation | |
| c) | Price and volume | Price | Volume |
| 0.00 | 21,073 | ||
| d) | Aggregated information | ||
| - Aggregated volume | 21,073 share options | ||
| - Price | DKK 0.00 | ||
| e) | Date of the transaction | 2022-01-25, 12:00 UTC | |
| f) | Place of the transaction | Outside a trading venue | |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Nicolai Buhl Andersen | |
| 2 | Reason for the notification | ||
| a) | Position/status | Executive Vice President, Innovation | |
| b) | Initial notification/Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor | ||
| a) | Name | Coloplast A/S (CVR-no.: 69749917) | |
| b) | LEI | 529900NN7SOJ5QG82X67 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Share options relating to B shares | |
| Identification code | ISIN: DK0060448595 (B shares) | ||
| b) | Nature of the transaction | Share option allocation | |
| c) | Price and volume | Price | Volume |
| 0.00 | 18,797 | ||
| d) | Aggregated information | ||
| - Aggregated volume | 18,797 share options | ||
| - Price | DKK 0.00 | ||
| e) | Date of the transaction | 2022-01-25, 12:00 UTC | |
| f) | Place of the transaction | Outside a trading venue | |
For further information, please contact
Investors and analysts
Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111
Ellen Bjurgert
Vice President, Investor Relations
Tel. +45 4911 1800 /+45 4911 3376
Email: dkebj@coloplast.com
Aleksandra Dimovska
Sr. Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 2458
Email: dkadim@coloplast.com
Press and the media
Dennis Kaysen
Sr. Director, Communications
Tel. +45 4911 2608
Email: dkdk@coloplast.com
Address
Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Denmark
Company reg. (CVR) no. 69749917
Website
www.coloplast.com
This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.
Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,500 employees.
The Coloplast logo is a registered trademark of Coloplast A/S. © 2022-01.
All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.
Dennis Kaysen Sr. Director, Communications Tel. +45 4911 2608 Email: dkdk@coloplast.com
